Posted by Clinical Lab Products | Apr 30, 2009 | Cancer, Miscellaneous, Tissue Processing |
Many studies determine hormone levels in the blood as a marker of breast cancer risk. But it hasnt been known whether these blood tests reflect what is happening in the breast tissue, where certain hormones fuel cancer.
Read MorePosted by Clinical Lab Products | Mar 27, 2009 | Biochemicals & Chemical Reagents, Cancer, Unknown Origin & Other Cancer Types |
BioMosaics Inc, a cancer biomarker development company, announced today that its monoclonal antibody product (clone 1G12) for detection of Glypican-3 (GPC3) has been validated for use as an immunohistochemical test for diagnosis of Hepatocellular Carcinoma (HCC).
Read MorePosted by Clinical Lab Products | Mar 9, 2009 | Miscellaneous |
B-R-A-H-M-S Aktiengesellschaft announces that it has submitted 510(k) file to the FDA to market its patented B-R-A-H-M-S MR-proANP Kryptor Test.
Read MorePosted by Clinical Lab Products | Feb 6, 2009 | Cancer, Miscellaneous |
The world in vitro diagnostic test market won’t be stalled by economic conditions for a variety of reasons, according to Kalorama Information.
Read MorePosted by Clinical Lab Products | Jan 13, 2009 | Miscellaneous |
A new national study has shown that nearly 75% of patients hospitalized for a heart attack had cholesterol levels that would indicate they were not at high risk for a cardiovascular event.
Read More